| Primary |
| Convulsion |
41.5% |
| Epilepsy |
25.6% |
| Hypertension |
4.0% |
| Convulsion Prophylaxis |
3.4% |
| Grand Mal Convulsion |
3.4% |
| Partial Seizures |
2.8% |
| Brain Injury |
2.3% |
| Prophylaxis |
2.3% |
| Depression |
1.7% |
| Maintenance Of Anaesthesia |
1.7% |
| Arthralgia |
1.1% |
| Atrial Fibrillation |
1.1% |
| Constipation |
1.1% |
| Dizziness |
1.1% |
| Drug Use For Unknown Indication |
1.1% |
| Glioma |
1.1% |
| Hypercholesterolaemia |
1.1% |
| Hyperuricaemia |
1.1% |
| Lennox-gastaut Syndrome |
1.1% |
| Myocardial Ischaemia |
1.1% |
|
| Stevens-johnson Syndrome |
36.2% |
| Convulsion |
14.6% |
| Drug Ineffective |
4.6% |
| Anticonvulsant Drug Level Below Therapeutic |
3.8% |
| Gastrostomy Tube Insertion |
3.8% |
| Grand Mal Convulsion |
3.8% |
| Rash |
3.8% |
| Death |
3.1% |
| Drug Level Below Therapeutic |
3.1% |
| Epilepsy |
3.1% |
| Therapeutic Agent Toxicity |
3.1% |
| Dysphagia |
2.3% |
| Loss Of Consciousness |
2.3% |
| Nausea |
2.3% |
| Therapeutic Response Unexpected With Drug Substitution |
2.3% |
| Anticonvulsant Drug Level Above Therapeutic |
1.5% |
| Blood Pressure Increased |
1.5% |
| Drug Effect Decreased |
1.5% |
| Hair Texture Abnormal |
1.5% |
| Hallucination |
1.5% |
|
| Secondary |
| Epilepsy |
33.9% |
| Convulsion |
17.6% |
| Product Used For Unknown Indication |
12.2% |
| Drug Use For Unknown Indication |
4.5% |
| Status Epilepticus |
3.6% |
| Partial Seizures With Secondary Generalisation |
2.9% |
| Depression |
2.7% |
| Grand Mal Convulsion |
2.7% |
| Hypertension |
2.4% |
| Encephalitis |
2.2% |
| Complex Partial Seizures |
2.0% |
| Gastritis Prophylaxis |
2.0% |
| Tuberous Sclerosis |
2.0% |
| Convulsion Prophylaxis |
1.6% |
| Altered State Of Consciousness |
1.3% |
| Constipation |
1.3% |
| Headache |
1.3% |
| Infection |
1.3% |
| Partial Seizures |
1.3% |
| Back Pain |
1.1% |
|
| Epilepsy |
10.3% |
| Cyanosis |
7.7% |
| Drug Ineffective |
6.4% |
| Headache |
6.4% |
| Liver Disorder |
6.4% |
| Stevens-johnson Syndrome |
6.4% |
| Convulsion |
5.1% |
| Drug Level Below Therapeutic |
5.1% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
5.1% |
| Loss Of Consciousness |
5.1% |
| Altered State Of Consciousness |
3.8% |
| C-reactive Protein Increased |
3.8% |
| Drug Eruption |
3.8% |
| Gingival Hyperplasia |
3.8% |
| Incontinence |
3.8% |
| Lymphadenopathy |
3.8% |
| Nikolsky's Sign |
3.8% |
| Poor Venous Access |
3.8% |
| Agranulocytosis |
2.6% |
| Blood Pressure Increased |
2.6% |
|
| Concomitant |
| Epilepsy |
28.3% |
| Prophylaxis |
15.8% |
| Drug Use For Unknown Indication |
8.4% |
| Convulsion |
6.4% |
| Pneumonia |
4.9% |
| Hypertension |
3.9% |
| Complex Partial Seizures |
3.4% |
| Product Used For Unknown Indication |
3.1% |
| Cerebrovascular Accident Prophylaxis |
2.9% |
| Insomnia |
2.6% |
| Breast Cancer Recurrent |
2.4% |
| Metastases To Bone |
2.4% |
| Simple Partial Seizures |
2.4% |
| Bipolar I Disorder |
2.3% |
| Anticoagulant Therapy |
1.9% |
| Convulsion Prophylaxis |
1.9% |
| Infection |
1.9% |
| Anaemia |
1.8% |
| Nuclear Magnetic Resonance Imaging |
1.6% |
| Cerebral Infarction |
1.5% |
|
| Epilepsy |
12.7% |
| Urine Abnormality |
7.6% |
| Pyrexia |
6.8% |
| Pancytopenia |
5.9% |
| Potentiating Drug Interaction |
5.9% |
| Abnormal Behaviour |
5.1% |
| Agranulocytosis |
5.1% |
| White Blood Cell Count Increased |
5.1% |
| Caesarean Section |
4.2% |
| Death |
4.2% |
| Hepatic Function Abnormal |
4.2% |
| Respiratory Arrest |
4.2% |
| Weight Decreased |
4.2% |
| White Blood Cell Count Decreased |
4.2% |
| Cerebral Infarction |
3.4% |
| Convulsion |
3.4% |
| Delirium |
3.4% |
| Dysphagia |
3.4% |
| Loss Of Consciousness |
3.4% |
| Platelet Count Decreased |
3.4% |
|
| Interacting |
| Immunosuppression |
28.3% |
| Drug Use For Unknown Indication |
17.0% |
| Epilepsy |
13.2% |
| Pneumonia |
11.3% |
| Pain |
7.5% |
| Fungaemia |
5.7% |
| Grand Mal Convulsion |
5.7% |
| Migraine |
3.8% |
| Status Epilepticus |
3.8% |
| Suicide Attempt |
3.8% |
|
| Overdose |
43.8% |
| Kidney Transplant Rejection |
18.8% |
| Epilepsy |
12.5% |
| Weight Decreased |
12.5% |
| Haemodynamic Instability |
6.3% |
| Renal Failure |
6.3% |
|
